Back to Results
First PageMeta Content



DNDi and Four Pharmaceutical Companies Announce ‘Drug Discovery Booster’ Experiment to Accelerate and Expand Discovery of New Drugs for Two Highly Neglected Diseases – Leishmaniasis and Chagas disease First multi-c
Add to Reading List

Document Date: 2015-06-01 01:11:46

Open Document

File Size: 374,04 KB

Share Result on Facebook

City

Geneva / Osaka / New York / Tokyo / London / /

Company

Takeda Pharmaceuticals / Pharmaceutical Ltd / Eisai Co Ltd / Takeda AstraZeneca plc / Takeda Pharmaceutical Company Limited / Shionogi & Co Ltd / Takeda Pharmaceutical Limited / AstraZeneca AstraZeneca / DNDi / AstraZeneca plc / Four Pharmaceutical Companies / /

Continent

Africa / Asia / /

Country

Switzerland / Japan / United Kingdom / /

Currency

EUR / JPY / /

Event

Business Partnership / FDA Phase / /

IndustryTerm

innovation-driven biopharmaceutical / chemical starting point / meaningful solutions / chemical compounds / treatment for leishmaniasis or Chagas disease / pharmaceuticals / treatment of neglected tropical diseases / treatment of Chagas disease / simultaneous search process / /

MedicalCondition

HIV / Leishmaniasis / Chagas disease / obesity / pain/CNS disorders / specific filarial infections / Two Highly Neglected Diseases / parasitic diseases / neglected tropical diseases / malaria / Neglected Diseases / neuroscience diseases / late-stage sleeping sickness / diseases / each disease / infectious diseases / infection / visceral leishmaniasis / metabolic disease / inflammation / infectious disease / human African trypanosomiasis / /

Organization

GHIT Fund / Melinda Gates Foundation / Japanese Global Health Innovative Technology Fund / Japanese Government / /

Person

Haruo Naito / Isao Teshirogi / Bernard Pécoul / Garry Pairaudeau / BT / Yasuchika Hasegawa / Sian Bowen / /

/

Position

Head of External Sciences / Executive Director / Communications Manager / Representative Corporate Officer and CEO / CEO / Representative / President & CEO / SSG&PM / Director / Chairman / DNDi Communications Manager / /

Product

This compound / /

Technology

neuroscience / Drug Discovery / drug development / /

URL

www.shionogi.co.jp / www.takeda.com / www.astrazeneca.com / www.dndi.org / www.eisai.com / /

SocialTag